S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Clinical trial NCT00946712 · TERMINATED

Trial details

NCT number: NCT00946712
Sponsor: SWOG Cancer Research Network
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Large Cell Lung Carcinoma Recurrent Lung Adenocarcinoma Recurrent Squamous Cell Lung Carcinoma Stage IV Large Cell Lung Carcinoma Stage IV Lung Adenocarcinoma Stage IV Squamous Cell Lung Carcinoma

Start date: 2009-07-15
Primary completion: 2017-08-31
Enrollment: 1333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.